A detailed history of Wellington Management Group LLP transactions in Viatris Inc stock. As of the latest transaction made, Wellington Management Group LLP holds 61,874 shares of VTRS stock, worth $722,069. This represents 0.0% of its overall portfolio holdings.

Number of Shares
61,874
Previous 77,500 20.16%
Holding current value
$722,069
Previous $823,000 12.76%
% of portfolio
0.0%
Previous 0.0%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$10.32 - $12.13 $161,260 - $189,543
-15,626 Reduced 20.16%
61,874 $718,000
Q2 2024

Aug 13, 2024

BUY
$10.05 - $12.02 $50,471 - $60,364
5,022 Added 6.93%
77,500 $823,000
Q1 2024

May 15, 2024

BUY
$11.27 - $13.53 $816,827 - $980,627
72,478 New
72,478 $865,000
Q4 2023

Feb 12, 2024

BUY
$8.77 - $10.85 $675,526 - $835,742
77,027 New
77,027 $834,000
Q2 2023

Aug 14, 2023

SELL
$9.02 - $10.29 $844,272 - $963,143
-93,600 Reduced 86.93%
14,070 $140,000
Q1 2023

May 12, 2023

BUY
$9.2 - $12.26 $898,481 - $1.2 Million
97,661 Added 975.73%
107,670 $1.04 Million
Q4 2022

Feb 13, 2023

BUY
$8.72 - $11.56 $87,278 - $115,704
10,009 New
10,009 $111,000
Q4 2021

Feb 11, 2022

SELL
$12.09 - $14.68 $19.5 Million - $23.7 Million
-1,611,950 Reduced 2.84%
55,233,099 $747 Million
Q3 2021

Nov 15, 2021

SELL
$13.25 - $15.13 $62.8 Million - $71.8 Million
-4,742,524 Reduced 7.7%
56,845,049 $770 Million
Q2 2021

Aug 16, 2021

SELL
$12.97 - $16.15 $54.5 Million - $67.8 Million
-4,201,074 Reduced 6.39%
61,587,573 $880 Million
Q1 2021

May 17, 2021

SELL
$13.59 - $18.54 $54.7 Million - $74.6 Million
-4,022,563 Reduced 5.76%
65,788,647 $919 Million
Q4 2020

Feb 12, 2021

BUY
$14.3 - $18.74 $998 Million - $1.31 Billion
69,811,210 New
69,811,210 $1.31 Billion

Others Institutions Holding VTRS

About Viatris Inc


  • Ticker VTRS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,212,669,952
  • Market Cap $14.2B
  • Description
  • Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...
More about VTRS
Track This Portfolio

Track Wellington Management Group LLP Portfolio

Follow Wellington Management Group LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wellington Management Group LLP, based on Form 13F filings with the SEC.

News

Stay updated on Wellington Management Group LLP with notifications on news.